Employees of the Nizhny Novgorod Research Institute of Epidemiology and Microbiology have created genetically engineered prototypes of vaccines against HIV infection and coronavirus, according to the website of the Government of the Nizhny Novgorod Region.
It is noted that the coronavirus vaccine being developed in Nizhny Novgorod is mucosal, it can be dripped into the nose.
The HIV vaccine is being jointly conducted by scientists from Novosibirsk and St. Petersburg with colleagues from Nizhny Novgorod. Negotiations have already been held with Privolzhsky Research Medical University on the organization of preclinical and clinical trials. In addition, work is underway to attract Russian investors who can provide production facilities.
Earlier, the head of Rospotrebnadzor Anna Popova said that several Russian research centers, including the State Research Center for Virology and Biotechnology “Vector”, are developing a vaccine against HIV.
We add that at the end of last year, the State Strategy for Countering the Spread of HIV Infection in the Russian Federation until 2030 was approved,